Real-world effectiveness of warfarin therapy for stroke prevention in medicare beneficiaries of all races

被引：0
|
作者：
Gage, B
Birman-Deych, E
Nilasena, DS
Radford, MJ
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Ctr Medicare, Dallas, TX USA
[3] Ctr Medicaid Serv, Dallas, TX USA
[4] Yale New Haven Hlth Syst, Ctr Outcomes Rsch & Evaluat, New Haven, CT USA
来源：
STROKE | 2005年 / 36卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：424 / 424
页数：1
相关论文
共 50 条
  • [21] Real-world effectiveness
    Schiermeier, Quirin
    [J]. NATURE, 2021, 598 (7882) : 553 - 553
  • [22] Hazards of thrombolytic therapy for stroke: the real-world experience
    Hurley, J. C.
    [J]. INTERNAL MEDICINE JOURNAL, 2007, 37 (05) : 348A - 349
  • [23] Real-World Treatment Trends in Endovascular Stroke Therapy
    Saber, Hamidreza
    Navi, Babak B.
    Grotta, James C.
    Kamel, Hooman
    Bambhroliya, Arvind
    Vahidy, Farhaan S.
    Chen, Peng Roc
    Blackburn, Spiros
    Savitz, Sean I.
    McCullough, Louise
    Sheth, Sunil A.
    [J]. STROKE, 2019, 50 (03) : 683 - 689
  • [24] Real-World Effectiveness of Statin Therapy in Adult Asthma
    Park, ChulHyoung
    Jang, Jae-Hyuk
    Kim, Chungsoo
    Lee, Youngsoo
    Lee, Eunyoung
    Yang, Hyoung-Mo
    Park, Rae Woong
    Park, Hae-Sim
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (02): : 399 - 408.e6
  • [25] Effectiveness of Bisphosphonate Therapy in a Real-World Setting.
    Feldstein, A. C.
    Weycker, D.
    Nichols, G. A.
    Oster, G.
    Rosales, G.
    Perrin, N.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S463 - S463
  • [26] Real-World Effectiveness of Primary ICDs Implanted during Unplanned Medicare Hospitalizations
    Chen, Chih-Ying
    Stewart, Garrick C.
    Stevenson, Lynne W.
    Bhatt, Deepak L.
    Desai, Manisha
    Seeger, John D.
    Williams, Lauren
    Jalbert, Jessica J.
    Setoguchi, Soko
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 28 - 28
  • [27] A Study of Real-World Data Races in Golang
    Chabbi, Milind
    Ramanathan, Murali Krishna
    [J]. PROCEEDINGS OF THE 43RD ACM SIGPLAN INTERNATIONAL CONFERENCE ON PROGRAMMING LANGUAGE DESIGN AND IMPLEMENTATION (PLDI '22), 2022, : 474 - 489
  • [28] COST-EFFECTIVENESS ANALYSIS OF DABIGATRAN VERSUS RIVAROXABAN FOR NON-VALVULAR ATRIAL FIBRILLATION USING REAL-WORLD EVIDENCE IN MEDICARE BENEFICIARIES
    Peng, S.
    Deger, K.
    Ustyugova, A., V
    Gandhi, P.
    Qiao, N.
    Wang, C.
    Kansal, A.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A269 - A270
  • [29] COST-EFFECTIVENESS ANALYSIS OF DABIGATRAN COMPARED TO WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION IN A MEDICARE POPULATION
    Ward, M. A.
    Biddle, A. K.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A121 - A121
  • [30] Cost Efficiency of Anticoagulation With Warfarin to Prevent Stroke in Medicare Beneficiaries With Nonvalvular Atrial Fibrillation
    Mercaldi, Catherine J.
    Ciarametaro, Mike
    Hahn, Beth
    Chalissery, George
    Reynolds, Matthew W.
    Sander, Stephen D.
    Samsa, Gregory P.
    Matchar, David B.
    [J]. STROKE, 2011, 42 (01) : 112 - 118
12345